Parisa Jorjani is of counsel in the firm’s Intellectual Property Group. Ms. Jorjani focuses her practice on patent litigation and counseling. Her patent litigation practice includes district court, arbitration and appellate experience, as well as experience in related proceedings, such as reexamination requests, interference proceedings and interference appeals. Her cases have involved a variety of life sciences and medical device technologies. Ms. Jorjani also has experience in district court and appellate proceedings under the Hatch-Waxman Act.
Before joining the firm, Ms. Jorjani practiced patent prosecution and trademark litigation. Ms. Jorjani also worked as a research associate in the Process Development group at Bayer Healthcare, where she focused on the design, execution and scale-up of novel fermentation processes.
Ms. Jorjani earned a B.S. degree in chemical engineering (with an emphasis in biotechnology) from the University of California at Berkeley in 1996. She received her law degree cum laude from Hastings College of the Law in 1999, where she was a member of the Communications and Entertainment Law Journal. Ms. Jorjani also served as a judicial extern for the Honorable Marilyn Hall Patel, Chief Judge, Northern District of California.
Ms. Jorjani is a member of the Federal Circuit Bar Association, the American Intellectual Property Law Association, and the San Francisco Intellectual Property Law Association.
Ms. Jorjani is admitted to practice before the United States Patent and Trademark Office.
Therasense, Inc. v. Becton, Dickinson & Co. et al.
(Northern District of California). Represented Bayer Healthcare in patent litigation involving diabetes test strips, as well as the subsequent Federal Circuit appeal and hearing en banc. Case was decided favorably for the client the after trial on inequitable conduct, ultimately resulting in a shift in the legal standard for inequitable conduct.
Estech v. Medtronic
(Northern District of California). Represented Medtronic in a patent infringement suit involving Estech’s minimally invasive beating heart surgery devices. Case settled on favorable terms.
Luciw v. Chang
(U.S. Patent and Trademark Office). Represented Chiron in patent interference involving patents and applications related to HIV immunoassays. Case was decided favorably for the client, with patent awarded to Chiron.
Roche Diagnostics v. Bayer Healthcare
(Arbitration based in New York). Represented Bayer Healthcare in arbitration involving diabetes test strips. Case settled on favorable terms.
MedImmune, Inc. v. Celltech R&D, Ltd.
(District of Columbia). Represented Celltech in patent litigation involving humanized monoclonal antibodies. Case settled on favorable terms.
Takeda, Inc. v. Impax Laboratories
(Northern District of California). Represent Impax in two patent litigation matters against Takeda brought under the Hatch-Waxman Act, involving Impax’s proposed generic dexlansoprazole product for the treatment of acid reflux disease. Prevailed on summary judgment of noninfringement of patent with latest expiration date in the first case, with the second case currently pending.
Allergan v. Sandoz
(Eastern District of Texas). Represent Sandoz in a patent litigation matter brought under the Hatch-Waxman Act, involving Sandoz’s proposed generic glaucoma eye drops. The case is currently stayed.